Overview
Maribel Medina-Aguilar practices practicing medicine in Culiacan, Mexico.
Her clinical expertise encompasses Leprosy, Colorectal Cancer, and Familial Colorectal Cancer.
She is actively involved in clinical research, co-authoring 29 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maribel Medina-Aguilar
Is Maribel Medina-Aguilar a top-rated expert for Leprosy?
MediFind is an objective health platform that identifies experts based on real-world data. Maribel Medina-Aguilar is classified as an Experienced expert for Leprosy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maribel Medina-Aguilar participate in research or clinical trials?
Yes. Maribel Medina-Aguilar has published 29 articles and abstracts on conditions like Leprosy. You can view a list of Maribel Medina-Aguilar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerMs. Medina-Aguilar isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerMs. Medina-Aguilar isExperienced. Learn about Familial Colorectal Cancer.
- LeprosyMs. Medina-Aguilar isExperienced. Learn about Leprosy.